301 related articles for article (PubMed ID: 20739209)
1. [Nonsurgical management of hepatocellular carcinoma].
Merle P; Mornex F
Cancer Radiother; 2010 Oct; 14(6-7):469-73. PubMed ID: 20739209
[TBL] [Abstract][Full Text] [Related]
2. Contemporary management of hepatocellular carcinoma.
Palmer D
Clin Med (Lond); 2008 Aug; 8(4):442-7. PubMed ID: 18724617
[No Abstract] [Full Text] [Related]
3. Current management of hepatocellular carcinoma.
Mendizabal M; Reddy KR
Med Clin North Am; 2009 Jul; 93(4):885-900, viii. PubMed ID: 19577120
[TBL] [Abstract][Full Text] [Related]
4. Current Standard and Future Perspectives in Non-Surgical Therapy for Hepatocellular Carcinoma.
Eggert T; Greten TF
Digestion; 2017; 96(1):1-4. PubMed ID: 28605745
[TBL] [Abstract][Full Text] [Related]
5. [The hepatocellular carcinoma: alternative therapeutical strategies].
Spangenberg HC; Thimme R; Mohr L; Blum HE
Zentralbl Chir; 2007 Aug; 132(4):322-7. PubMed ID: 17724635
[TBL] [Abstract][Full Text] [Related]
6. [Current therapy for hepatocellular carcinoma].
Ikeda K
Nihon Rinsho; 2010 Jun; 68(6):1129-36. PubMed ID: 20535967
[TBL] [Abstract][Full Text] [Related]
7. Multimodality therapy and liver transplantation for hepatocellular carcinoma: a 14-year prospective analysis of outcomes.
Ramanathan R; Sharma A; Lee DD; Behnke M; Bornstein K; Stravitz RT; Sydnor M; Fulcher A; Cotterell A; Posner MP; Fisher RA
Transplantation; 2014 Jul; 98(1):100-6. PubMed ID: 24503764
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review.
Han K; Kim JH; Ko GY; Gwon DI; Sung KB
World J Gastroenterol; 2016 Jan; 22(1):407-16. PubMed ID: 26755886
[TBL] [Abstract][Full Text] [Related]
9. [Treatment approach of hepatocellular carcinoma in Spain. Analysis of 705 patients from 62 centers].
Varela M; Reig M; de la Mata M; Matilla A; Bustamante J; Pascual S; Turnes J; Aracil C; Del Val A; Pascasio JM; Rodríguez M; Bruix J
Med Clin (Barc); 2010 May; 134(13):569-76. PubMed ID: 20036398
[TBL] [Abstract][Full Text] [Related]
10. New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.
Woo HY; Heo J
Clin Mol Hepatol; 2015 Jun; 21(2):115-21. PubMed ID: 26157747
[TBL] [Abstract][Full Text] [Related]
11. Update on Embolization Therapies for Hepatocellular Carcinoma.
Kishore S; Friedman T; Madoff DC
Curr Oncol Rep; 2017 Jun; 19(6):40. PubMed ID: 28421483
[TBL] [Abstract][Full Text] [Related]
12. A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib.
de la Torre MA; Buades-Mateu J; de la Rosa PA; Lué A; Bustamante FJ; Serrano MT; Testillano M; Lorente S; Arenas JI; Gil C; Iñarrairaegui M; Sangro B
Liver Int; 2016 Aug; 36(8):1206-12. PubMed ID: 26910784
[TBL] [Abstract][Full Text] [Related]
13. Yttrium-90 radioembolization for hepatocellular carcinoma: what we know and what we need to know.
Kim YH; Kim DY
Oncology; 2013; 84 Suppl 1():34-9. PubMed ID: 23428856
[TBL] [Abstract][Full Text] [Related]
14. [A case of advanced hepatocellular carcinoma with portal vein invasion successfully treated by sorafenib].
Endo Y; Miyamoto M; Koujima T; Watanabe Y; Kawai T; Toda K; Nobuhisa T; Watanabe T; Matsumoto Y; Watanabe N; Kai K; Sato S
Gan To Kagaku Ryoho; 2012 Jun; 39(6):963-5. PubMed ID: 22705693
[TBL] [Abstract][Full Text] [Related]
15. Recurrent hepatocellular carcinoma in liver transplant recipients: parameters affecting time to recurrence, treatment options and survival in the sorafenib era.
Pfiffer TE; Seehofer D; Nicolaou A; Neuhaus R; Riess H; Trappe RU
Tumori; 2011; 97(4):436-41. PubMed ID: 21989430
[TBL] [Abstract][Full Text] [Related]
16. Complete Remission of Unresectable Hepatocellular Carcinoma After Combined Sorafenib and Adjuvant Yttrium-90 Radioembolization.
Lorenzin D; Pravisani R; Leo CA; Bugiantella W; Soardo G; Carnelutti A; Umberto B; Risaliti A
Cancer Biother Radiopharm; 2016 Mar; 31(2):65-9. PubMed ID: 26986817
[TBL] [Abstract][Full Text] [Related]
17. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis.
Lee JM; Jang BK; Lee YJ; Choi WY; Choi SM; Chung WJ; Hwang JS; Kang KJ; Kim YH; Chauhan AK; Park SY; Tak WY; Kweon YO; Kim BS; Lee CH
Clin Mol Hepatol; 2016 Mar; 22(1):160-7. PubMed ID: 27044767
[TBL] [Abstract][Full Text] [Related]
18. How to improve treatment outcomes for hepatocellular carcinoma of intermediate and advanced stage.
Kim DY; Han KH
Dig Dis; 2012; 30(6):598-602. PubMed ID: 23258101
[TBL] [Abstract][Full Text] [Related]
19. [Clinical analysis of the treatment:transcatheter arterial chemoembolization combined with sorafenib in advanced hepatocellular carcinoma].
Li Y; Huang JW; Lu LG; Shao PJ; Hu BS; Huang GM; Wei ZG; Zhang L
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2187-92. PubMed ID: 21029658
[TBL] [Abstract][Full Text] [Related]
20. [Transarterial chemoembolization and conformal radiotherapy for hepatocellular carcinoma].
Merle P; Mornex F
Cancer Radiother; 2011 Feb; 15(1):69-71. PubMed ID: 21237690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
